DescriptionDetection of drug resistance genes using MALBAC.jpg
English: Solid tumours are often genetically heterogenous, and exposure of the tumour to chemotherapeutic agents may select for the outgrowth of resistant clones. MALBAC may be used as an unbiased approach to amplify DNA from a single drug resistant clone. After the creation of looped amplicons using five cycles of MALBAC, PCR may be applied to amplify tumour DNA exponentially. This then allows for the DNA sequence of a single drug resistant clone to be analyzed.
to share – to copy, distribute and transmit the work
to remix – to adapt the work
Under the following conditions:
attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.